Skip to main content
Clinical Trials/NL-OMON40572
NL-OMON40572
Completed
Not Applicable

Assessment of inflammatory markers in patients with ulcerative colitis treated with tofacitinib - Inflammatory markers in UC

Academisch Medisch Centrum0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ulcerative colitis
Sponsor
Academisch Medisch Centrum
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. patients (\*18 years) with ulcerative colitis with an indication to start Tofacitinib within the OCTAVE induction study (METC2012\_072\) and responding to this therapy
  • 2\. patients (\*18 years) with ulcerative colitis with an indication to start Tofacitinib within the Open Label study (METC\_075\), after having been defined as a non\-responder within the participation in the OCTAVE Induction study (METC2012\_072\)

Exclusion Criteria

  • subjects without previous treatment for UC

Outcomes

Primary Outcomes

Not specified

Similar Trials